Skip Page Header

Home > Consideration of the major cannabinoid agonists.

Advisory Council on the Misuse of Drugs. [Home Office UK] (2009) Consideration of the major cannabinoid agonists. London: Home Office. 29 p.

[img]
Preview
PDF (Cannabinoid agonists) - Published Version
131kB

This report draws on much of the evidence cited in the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) assessment of the synthetic cannabinoid receptor agonists, based on an expert meeting held in Lisbon on 6th March 2009.

[For an updated report see the related link below.]


Item Type
Evidence resource
Publication Type
Report
Drug Type
Cannabis, CNS stimulants
Intervention Type
AOD disorder harm reduction
Date
2009
Pages
29 p.
Publisher
Home Office
Corporate Creators
Advisory Council on the Misuse of Drugs
Place of Publication
London
EndNote
Accession Number
HRB (Electronic Only)
Related URLs

Repository Staff Only: item control page